Table 2.

Characteristics of participants in the training and validation data set for metabolic syndrome.

Characteristics		Training data set (n=904)		Validation data set (n=225)
Sex
	Female, n (%)		411 (45.5)		108 (48.0)
	Male, n (%)		493 (54.5)		117 (52.0)
Age, years, median (IQR)		44 (37-50.25)		43 (38-50)
Body mass index, kg/m2, median (IQR)		23.6 (21.3-25.9)		22.9 (21.2-26)
Waist circumference, cm, median (IQR)		81.75 (74.5-88)		80.5 (74-87)
Albumin, g/dL, median (IQR)		4.6 (4.4-4.8)		4.6 (4.4-4.8)
Alkaline phosphatase, IU/L, median (IQR)		58 (49-69)		58 (48-69)
Glutamic-oxaloacetic transaminase, IU/L, median (IQR)		20 (17-24.25)		20 (17-25)
Glutamate pyruvate transaminase, IU/L, median (IQR)		20 (14-31)		19 (14-28)
Total bilirubin, mg/dL, median (IQR)		0.6 (0.5-0.9)		0.6 (0.4-0.8)
γ-Glutamyl transpeptidase, U/L, median (IQR)		18 (12-27)		17 (11.55-25)
Controlled attenuation parameter (CAP) score, dB/m, median (IQR)		247 (211-284)		241 (216-282)
Elastic modulus (E) score, kPa, median (IQR)		4.2 (3.4-4.9)		4 (3.3-4.8)
Blood urea nitrogen, mg/dL, median (IQR)		12 (10-15)		12 (10-14)
Creatinine, mg/dL, median (IQR)		0.8 (0.6-0.9)		0.8 (0.6-0.9)
Estimated glomerular filtration rate (eGFR) using the Modification of Diet in Renal Disease (MDRD) equation, median (IQR)		90.23 (80.49-104.77)		91.28 (82.72-107.26)
Uric acid, mg/dL, median (IQR)		5.5 (4.5-6.6)		5.4 (4.3-6.6)
Systolic blood pressure, mm Hg, median (IQR)		114 (105-125)		114 (105-126)
Diastolic blood pressure, mm Hg, median (IQR)		73 (67-80)		72 (66-81)
Cholesterol, mg/dL, median (IQR)		189 (165-209)		185 (168-209)
Triglycerides, mg/dL, median (IQR)		90 (65-135.2)		86 (63-126)
High-density lipoprotein, mg/dL, median (IQR)		55(45-67)		54 (47-66)
Low-density lipoprotein, mg/dL, median (IQR)		123 (102-145)		123 (102-145)
Hemoglobin A1c, %, median (IQR)		5.4 (5.2-5.6)		5.4 (5.2-5.5)
Glucose AC, mg/dL, median (IQR)		91 (86-96)		90 (85-95)